PLEASE JOIN US FOR THE

EAO CRC SUMMIT 2019

Thursday, May 2, 2019, 7:30 am – 5:00 pm 
Friday, May 3, 2018, 7:30 am – 12:00 pm

1st Annual Colorectal Cancer Heroes event to be held Thursday evening

New York, NY 

Performing a Knowledge GAP Analysis and

Building a Strategic “Action Plan” to Reduce EAO-CRC Incidence & Mortality

 

SCHEDULE

Download in PDF format

Thursday, April 26 4:00 – 7:30 PM Family Health History Symposium – Transforming Family Health History Ascertainment and Colorectal Cancer Preventive Services in Primary Care: A National Colorectal Cancer Roundtable Family History Early Age Onset Task Group Special Meeting
Thursday, April 26 7:30 – 8:30 PM President’s Reception
Friday, April 27 7:30 AM – 8:00 PM Continental Breakfast and Registration
Friday, April 27 8:00 AM – 8:15 AM
Welcome And Overview Of The Day: Framing The Conversation
Friday, April 27 8:15 AM – 8:45 AM Keynote Address: Rebecca Siegel, MPH
Friday, April 27 8:45 AM – 9:45 AM Part I: “The Usual Suspects”: A Closer Look – Persons of Interest
Friday, April 27 9:45 AM – 10:00 AM Networking Coffee Break/Exhibitor Hall Open
Friday, April 27 10:00 AM – 11:35 AM Part II: Life Course Epidemiology: Additional Possible Causes Of Young Onset Colorectal Cancer
Friday, April 27 11:35 AM – 1:15 PM Lunch and Learn Breakout Sessions: “Demystifying Genetic Testing – From A To Z”, “50 Is The Finish Line – Earlier Conversations Lead To On Time Evidence Based Screening”, and “New And Emerging Minimally Invasive Technologies Designed To Identify Individuals With Colorectal Cancer: Can These Methods Be Deployed To Protect Young Adults From delayed & Late Stage Diagnosis”
Friday, April 27 1:15 PM – 1:30 PM Networking Break/Exhibit Hall Open
Friday, April 27 1:30 PM – 2:55 PM Part II Continued: “Persons Of Interest”: Life Course And Neuveau Epidemiology: Additional Possible Causes of Microsatelite Stable (MSS) Young Onset Colorectal Cancer And How To Evaluate Them
Friday, April 27 2:55 PM – 3:10 PM Networking Coffee Break/Exhibit Hall Open
Friday, April 27 3:10 PM – 4:40 PM Part III: Current Efforts To Address EAO CRC Morbidity and Mortality: Causation Research: Adjusting Screening/Surveillance Guidelines: Family Health History and Earliest Possible Stage Diagnosis – the NCCRT Tool Kit Update
Friday, April 27 4:40 PM – 5:30 PM Group Discussion And Commitments To Next Steps, Meeting Summary And Overview Of The EAO CRC Strategic Plan Moving Forward

CO-CHAIRS

Thomas K. Weber MD FACS

Course Director and Host

Director of Surgical Oncology; Northwest Region at Northwell Health
Founder and President, Colon Cancer Foundation

Richard R. Barakat, MD, MBA, FACS

Course Co-Director

Founder, Raymond Foundation
Founding Co-Chair, GI Cancers Alliance

Susan K. Peterson PhD MPH

Poster Session Committee Chairperson

Professor of Behavioral Science
The University of Texas MD Anderson Cancer Center

COURSE OBJECTIVES

This event will bring together leading clinicians, scientists as well as early age onset (EAO) colorectal cancer (CRC) survivors and caregivers from across the country and internationally . The program will provide extensive opportunities for participants to advance their understanding of the rapidly increasing incidence of rectal and colon cancer among young adults under 50 years of age in the U.S. and abroad.

This groundbreaking program will, for a fifth consecutive year, provide all participants the opportunity to hear from and question leading clinicians and researchers on the life saving potential of timely clinical risk assessment/family cancer health history; earliest possible stage diagnosis, optimal, fertility preserving clinical care, as well as the latest information regarding national and international EAO-CRC incidence trends, pathogenesis, and genetics. In addition, this year’s program will present a “Research in Progress” segment featuring currently NCI funded and planned EAO CRC research  projects from across America and Europe. Again this year, important Break-Out Sessions based on needs-assessments from our survivor community will address challenging issues surrounding Palliative Care, support networks for “Caregivers” and a “Primer” on the “Epigenetics” of EAO-CRC specifically requested by our Young Adult CRC Survivor Program Advisory Group.

The course will include lectures, workshops and panel discussions designed to advance the “state-of-the-science” addressing EAO-CRC. Our faculty will once again be world class speakers representing leading academic medical centers with major additional inspiring programmatic contributions from the Early Age Onset Colorectal Cancer Survivor Community of the United States and beyond.

EDUCATIONAL OBJECTIVES

  • Provide an expert review of the latest published information on the increasing incidence and mortality associated with Early Age Onset Colorectal Cancer in the United States and globally.
  • Review the State-of-the-Science regarding the known and possible causes of the increasing incidence of EAO-CRC including alterations in our food and water supply, the contribution of novel germline genetic factors and etiologic clues based on the molecular biology of EAO-CRC cancers.
  • Provide an evidence-based framework for reducing risk, increasing early stage diagnosis and improving treatment and outcomes for young adult colorectal cancer patients.
  • Define the “Gaps” in our current understanding of Early Age Onset Colorectal Cancer in order to set our clinical and research priorities and develop a strategic plan to reduce EAO-CRC incidence and mortality

PLANNED PRESENTATIONS AND INVITED FACULTY INCLUDE

Download in PDF format

FRAMING THE CONVERSATION: STRATEGIC CHALLENGES IN CURRENT MEDICAL CARE THAT CONTRIBUTE TO YOUNG ADULT COLORECTAL CANCER (CRC) INCIDENCE AND MORTALITY. SURVIVOR TESTIMONIALS UNDERSCORE OPPORTUNITIES FOR IMPROVEMENT IN THE PREVENTION AND CARE OF YOUNG ADULT COLORECTAL CANCER.

Moderated By: Thomas K. Weber, MD, FACS, Northwell Health, Colon Cancer Foundation

SESSION I: THE DIMENSIONS OF THE EAO-CRC PROBLEM: TARGET ITEM: ACCURATE, REGULAR, UP TO DATE MEASUREMENT OF KEY METRICS DESCRIBING THE EARLY AGE ONSET COLORECTAL CANCER PUBLIC HEALTH CRISIS.

  • Overview of Global EAO-CRC Incidence Patterns and Trends

Nata Menabde, MsC, PhD, World Health Organization Office at the United Nations, New York

  • Overview of United States EAO-CRC Incidence Patterns and  Trends

Rebecca L. Siegel, MPH, American Cancer Society

  • Innovations in Centers for Disease Control (CDC) Cancer Registry Data Accrual in the Age of Genomic Medicine

Jordan Karlitz, MD, FACG Tulane University School of Medicine

  • Overview of European Cancer Registries Data Resources on EAO-CRC  

Irit Ben-Aharon, MD, PhD, Ranbam Health Care Campus, European Organisation for Research and Treatment of Cancer (EOCRT)

  • Overview of Healthcare System Resources and  National Institutes of Health (NIH)  Cohorts

Theodore Levin, MD, Kaiser Permanente Division of Research

Douglas A. Corley, MD, PhD, MPH, Kaiser Permanente Division of Research

Stephanie Smith-Warner, PhD, Harvard T.H. Chan School of Public Health

SESSION 1: FAMILY HISTORY ASCERTAINMENT IN THE U.S. (ADDRESSING  GAP 1) WHAT STEPS ARE NEEDED TO IMPROVE THE WELL DOCUMENTED LESS THAN OPTIMAL STATUS OF THIS SITUATION? WHAT IS OUR BEST INFORMATION ON THE DOCUMENTATION OF CANCER FAMILY HISTORY IN PRIMARY CARE?  WHAT ARE THE KEY ELEMENTS REQUIRED FOR SUCCESS.

Moderator: Gregory Feero, MD, PhD, Dartmouth Geisel School of Medicine

  • How and Why the Electronic Health Records (EHR) have failed? An objective professional assessment of where the problems lie. What 21st century “work arounds” do we have to help us address Family Health History documentation, interpretation and appropriate action?

Shelly Yu, American Cancer Society Cancer Action Network  

  • Review of National Colorectal Cancer Roundtable (NCCRT) Family Health History Early Age Onset Colorectal Cancer (EAO-CRC) Group Progress

Dennis Ahnen, MD, AGAF, FACG, University of COlorado School of Medicine Co-Chair National Colorectal Cancer Roundtable (NCCRT) Family History  Early Age Onset Colorectal Cancer Task Group

Paul Schroy, MD, MPH, Co-Chair National Colorectal Cancer Roundtable (NCCRT) Family History  Early Age Onset Colorectal Cancer Task Group

  • Implementation of the The NCCRT Risk Assessment and Screening Toolkit to Detect Familial, Hereditary and Early Onset Colorectal Cancer

Caleb Lavell, American Cancer Society, Program Manager National Colorectal Cancer Roundtable (NCCRT)

Emily Edelman MS, CGC The Jackson Laboratory for Genomic Medicine

  • Detecting Unaffected Individuals with Lynch Syndrome (DUAL).  

Sayoni Lahiri, MS, CGC, UT Southwestern Medical Center

  • Large Adenoma Prevalence and Family Health History Documentation

Christine Louise S. Molmenti, MPH. PhD Feinstein Institute for Medical Research, Northwell Health

  • Integrating content re: Family Health History Early Age Onset Colorectal Cancer into the entire continuum of medical and specialty education from medical school through Board Certification, CME and Recertification.
  • Cancer Family History as a Quality Assurance (QA) assessment and “regulatory” U.S. Centers for Medicare & Medicaid Services (CMS) issue?
  • The Future: What needs to be done and how are we going to do it?

Gregory Feero, MD, PhD, Dartmouth Geisel School of Medicine

SESSION II: EARLIEST POSSIBLE DIAGNOSIS AND TREATMENT THROUGH TIMELY RECOGNITION OF THE SYMPTOMS AND SIGNS OF YOUNG ADULT CRC (ADDRESSING GAP 2)

Moderator: Whitney Jones, MD, Midwest Gastroenterology Associates

  • A review of the published data supporting delays in diagnosis and the consequences in terms of later stage diagnosis and poorer outcomes

Whitney Jones, MD, Midwest Gastroenterology Associates

  • Overview of the continuum of providers who interact with patients prior to and up to a diagnosis

Chelsea Boet, MD, Spectrum Health Medical Group

  • Introduction of the EAO-CRC Clinical Alert and Signs and Symptoms Index

Andrew Albert, MD, MPH, Chicago Gastro LLC.

Erin Peterson, Colon Cancer Coalition

  • Provider Education Outreach Initiatives
  • Patient Awareness and Advocacy Initiatives

SESSION III: TIMELY, EFFECTIVE, QUALITY OF LIFE & FERTILITY PRESERVING STATE OF THE ART TREATMENT (ADDRESSING GAP 3)  

  • Updates in Medical Oncology

Andrea Cercek, MD, Memorial Sloan Kettering Cancer Center

Tony Philip, MD, FACP, Northwell Health Cancer Institute

Michael J. Hall, MD, MS, Department of Clinical Genetics.Fox Chase Cancer Center

  • Updates in Rectal Cancer Surgery for Young Adults

Jonathan Mitchem, MD, University of Missouri School of Medicine

  • Optimal Preservation of Fertility

Nicole Noyes MD, Reproductive Endocrinologist, Northwell Health

  • New, Available Treatments for Mismatch repair (MMR) deficient and MSS metastatic Colorectal Cancer

Cathy Eng, MD, FACP, FASCO, The University of Texas MD Anderson Cancer Center

  • Update on advances in immunotherapy: What new treatments are in the pipeline?

Joshua Smith, MD, PhD, Memorial Sloan Kettering Cancer Center

  • New, relevant, open for accrual clinical trials

Zsophia K. Stadler, MD, Memorial Sloan Kettering Cancer Center

  • Key elements of a Center for Early Age Onset Colorectal Cancer

Andrea Cercek, MD, Memorial Sloan Kettering Cancer Center

Zsophia K. Stadler, MD, Memorial Sloan Kettering Cancer Center

Zana Correa, NP, Memorial Sloan Kettering Cancer Center

Stacy Hurt, MHA, MBA, Colon Cancer Coalition

  • GAPS in providing Palliative Care and the cost benefit ratio for hospital systems

Lisa D. Morgan, Principal, LDM Strategies, Center to Advance Palliative Care (CAPC)

SESSION IV: HOW DID THIS HAPPEN? INVESTIGATING THE CAUSES OF EARLY ONSET COLORECTAL CANCERS (EAO-CRC) (ADDRESSING GAP 4)

  • The Genetics of Heritable CRC: What’s New and Important to Know Regarding the Genetics of EAO-CRC?

Mathew B. Yurgelun MD, Dana-Farber Cancer Institute, Harvard Medical School

Zsophia Stadler, MD, The Kenneth Offit Lab | Memorial Sloan Kettering Cancer Center

Heather Hampel, MS, LGC, Ohio State University Comprehensive Cancer Center

Elena Stoffel, MD, University of Michigan Rogel Cancer Center

Xavier Llor, MD, PhD, Cancer Genetics and Prevention Program. Yale New Haven Hospital

  • What is driving the increases in EAO-CRC,  80 plus percent of which is NOT related to the named hereditary syndromes?   
  • The Usual Suspects : New Data – Journal of the American Medical Association (JAMA) Obesity Study  

Yin Cao, MPH, ScD, MPH, Washington University School of Medicine

  • New Research Information: Current Efforts to investigate the causes of increases in MSS CRC among young adults.
      • The United States:
        • Current NCI Funded Investigations into the Causes of Early Age Onset Colorectal Cancer:
          • Colorectal Cancer Risks in People < 50 Years of Age  NIH Small Grant Program (RO3): Epidemiology
            • Richard Hayes, DDS, PhD, MPH, The Cancer Institute at NYU Langone
          • Integrating Diet, Lifestyle and Tumor Tissue Molecular Subtyping to Study the Role of Adolescent Calcium Intake on the Risk of Early Onset Colorectal Neoplasia (R21)
            • Kana Wu,MD, PhD, Harvard T.H. Chan School of Public Health, Dana-Farber, Harvard Cancer Center
      • The European Union: Funded Investigations
          • European Organization for Research and Treatment of Cancer (EORTC): Young Onset CRC: Causation, Treatment and Outcomes
            • Irit Ben-Aharon, MD, PhD, EOCRT European Organisation for Research and Treatment of Cancer
          • University of Madrid: Young Onset CRC in Spain and Italy: A Collaborative Study of the Biology of Young Onset CRC  
            • Jose Perea, MD, PhD, Fundacion Jimenez Diaz University Hospital
      • Studies in Development:
        • CRAYON: ColoRectal Cancer in Adults at Young ONset: New York City Based Prospective Accrual Study of Young Onset Colorectal Cancer: Beyond the Usual Suspects; Asking NEW Questions : Dissecting the Carcinogenic Exposome of the 20th Century : “What, When & Where”
          • Steven H. Itzkowitz MD, Icahn School of Medicine at Mount Sinai
          • Thomas F. Imperiale, MD, Regenstrief Institute, Inc., Indiana University Center for Health Services and Outcomes Research, Indiana University School of Medicine
        • An National Institutes of Health (NIH) Funded State of the Science “Huddle”
          • Thomas K. Weber, MD, FACS, Northwell Health

SESSION V: FAILURE TO PROVIDE PALLIATIVE CARE (INCLUDING GUIDANCE, SUPPORT AND RESOURCES TO ME AND MY CAREGIVERS DURING MY TREATMENT JOURNEY/CONTINUUM OF CARE.  (ADDRESSING GAP 5)

Moderators: Sarah Debord, Colon Cancer Coalition

Krista Nelson, LCSW, OSW-C, BCD, FAOSW, Association of Oncology Social Work

SESSION VI: EPIGENETICS AND ITS FUTURE ROLE IN THE DIAGNOSIS AND TREATMENT OF INDIVIDUALS MORE SPECIFICALLY AND ACCURATELY

Moderator: C. Richard Boland, MD, AGAF, UC San Diego

ACCOMMODATIONS

Please check back. The Colon Cancer Foundation will reserve a block of rooms as close to the venue as possible. 

Hotels in Midtown Manhattan

Hilton Garden Inn Hotel – Central Park South

237 W 54th St, New York, NY 10019

3.5 stars;  average room price – $289

http://www.hgicentralparknyhotel.com/#gref

Phone:(212) 253-6000

Courtyard Marriott – Central Park

1717 Broadway, New York, NY 10019  (Bet. 54th & 55th Street)

3.5 stars; average room price – $289

http://www.marriott.com/hotels/hotel-photos/nycpk-courtyard-new-york-manhattan-central-park/

Phone:  (212) 324-3773

Residence Inn – Marriott-Central Park

1717 Broadway, New York, NY 10019  (Bet. 54th & 55th Street)

3.5 Stars;  Average room price – $289

http://www.marriott.com/hotels/travel/nycpr-residence-inn-new-york-manhattan-central-park/

Phone:(212) 324-3774

Quin Hotel

101 West 57th Street at Sixth Avenue, New York, NY 10019

4.5 Stars:  Average room price – $250

http://www.thequinhotel.com/

Phone:  (212) 245-7846

Parker New York

119 W 56th St, New York, NY 10019

4 Stars:  Average room price $270

http://www.parkernewyork.com/home/

Phone:(212) 245-5000

Salisbury Hotel

123 W 57th St, New York, NY 10019

3 Stars;  Average room price $200

http://www.nycsalisbury.com/

Phone:(212) 246-1300

PARKING

There are many parking garages and lots in Midtown Manhattan. Please visit the three websites below for a thorough listing and assistance in pre paying for a reservation.

TRANSPORTATION

EMPIRE CLS WORLDWIDE CHAUFFEURED SERVICES

Transportation service from NYC airports is provided through Empire CLS Worldwide Chauffeured Services. Pricing can be viewed HERE.

SUPER SHUTTLE 

Super Shuttle serves John F. Kennedy International Airport (JFK), LaGuardia Airport (LGA), Newark Liberty International Airport (EWR), Long Island MacArthur Airport (ISP) and the surrounding areas.

Choose from:

  • Non-stop service (direct service from pickup to drop off, no stops)
  • Shared-ride (share the ride with others travelling in the same direction, may include stops)
  • Premium (private, chauffeured sedan or SUV service)

NYC TAXI

Alternatively there is a taxi stand at each NYC airport terminal.  Taxis from LGA are roughly $50.  From JFK they are a flat rate of $52 plus tolls and tip (About $65-$70 total). And from Newark (EWR) roughly $90-95.

UBER  

Uber picks up from all three airports as well and an “Uber X” would cost roughly the same amount as a taxi. The Uber app can be downloaded HERE.

INVITED FACULTY

This year the Summit will feature presentations from EAO-CRC survivors, caregivers clinicians from the nation’s leading cancer centers, and representatives of CRC advocacy organizations including American Cancer Society, Boston University School of Medicine, The Cancer Institute at NYU Langone, Chicago Gastro LLC., Columbia University, Colon Cancer Coalition, Colon Cancer Prevention Project, Dana-Farber, Harvard Cancer Institute, Dartmouth Geisel School of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Feinstein Institute for Medical Research, European Organization for Research and Treatment of Cancer, Fox Chase Cancer Center, Fundacion Jimenez Diaz University Hospital, Georgia State University, Harvard T.H. Chan School of Public Health, Institute for Biomedical Sciences, Icahn School of Medicine at Mt. Sinai Hospital, Indiana University School of Medicine, Jackson Laboratory for Genomic Medicine, Kaiser Permanente, Laura and Isaac Perlmutter Cancer Center, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, The Kenneth Offit Lab, Memorial Sloan Kettering Cancer Center, Michael’s Mission, Midwest Gastroenterology Associates, Mt. Sinai Medical Center, National Institutes of Health (NIH), National Colorectal Cancer Roundtable, the Never Too Young Coalition, New York Citywide Colon Cancer Control Coalition, New York University School of Medicine, Northwell Health Cancer Institute, The Ohio State University Comprehensive Cancer Center, The Raymond Foundation, Regenstrief Institute, Inc., Spectrum Health Medical Group, Tulane University School of Medicine, University of Chicago Medicine Comer Children’s Hospital, University of Colorado, UT Southwestern Medical Center, UCSD School of Medicine – San Diego, University of Michigan Rogel Cancer Center, World Health Organization, Yale New Haven Hospital.
Dennis J. Ahnen MD AGAF FACGUniversity of Colorado School of Medicine
Barry Berger, MD, FACPExact Sciences Corporation, Harvard Medical School, Brigham and Women’s Hospital, Boston MA
C. Richard Boland MD AGAFUCSD School of Medicine, San Diego
Durado Brooks, MD, MPHAmerican Cancer Society
Anne CarlsonColon Cancer Coalition
Benoit Chassaing PhDGeorgia State University, Institute for Biomedical Sciences
Sarah DebordColon Cancer Coalition
Noel DoehnyEpigenomics
David DubinSema4 Genomics, a Mount Sinai Venture, AliveAndKickn
Robin Beth Dubin, MBAAliveAndKickn
Emily Edelman, MS, CGC The Jackson Laboratory
Julienne Gede Edwards, MA, JDFight Colorectal Cancer
Vanessa GhighliottyPatient Advocate
Vivian GuayBracco Diagnostics
Heather Hampel MS LGCThe Ohio State University Comprehensive Cancer Center
Stacy Hurt, MHA, MBAColon Cancer Coalition
Whitney Jones MDMidwest Gastroenterology Associates, Colon Cancer Prevention Project

Maureen Killackey, MDNew York Presbyterian/Herbert Irving Comprehensive Cancer Center
Caleb LevellNational Colorectal Cancer Roundtable, American Cancer Society
Christine Louise S. Molmenti PhDFeinstein Institute for Medical Research, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Alan Murphy, BComm, MAcc, ACAPatient Advocate, KKR & Co., L.P.
Susan Pfau, MA, Marriage & Family TherapyMental Health Practitioner, Family Innovations, Children’s Therapy Skills Services
Swati G. Patel, MDUniversity of Colorado Anschutz Medical Center
Jose’ Perea MD PhDFundacion Jimenez Diaz University Hospital
Roni Caryn Rabin
New York Times
Susan Peterson PhD, MPH The University of Texas MD Anderson Cancer Center
Martha Raymond MA CPNMichael’s Mission, The Raymond Foundation
Jennifer Reich, MDOrange Regional Medical Center and Valley Hospital
Lanie Friedman Ross MD PhD The University of Chicago Medicine Comer Children’s Hospital
Benjamin Smith JDNew York Legal Assistance Group
Julia A. Smith MD, PhDLaura and Isaac Perlmutter Cancer Center
Paul Schroy III MD PhDBoston University School of Medicine
Ravi Sharaf MD MS Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Rebecca L. Siegel, MPHAmerican Cancer Society
Randa Sifri, MDThomas Jefferson University
Zsophia Stadler MDMemorial Sloan Kettering Cancer Center, The Kenneth Offit Lab
Thomas K. Weber MD FACSDirector of Surgical Oncology; Northwest Region at Northwell Health
Richard Woychik, PhDNational Institute of Environmental Sciences and National Toxicology Program
David Yavin PhD Medial Early Sign
Judy Yee, MD, FACRMontefiore Medical Center, Albert Einstein College of Medicine
Shelly Yu, MPH American Cancer Society
Ann Zauber, PhDCancer Intervention and Surveillance Modeling Network, Memorial Sloan Kettering Cancer Center

SPONSORS

SPONSORSHIP OPPORTUNITIES

The sponsors of the EAO-CRC Summit make it possible for us to build public awareness of colorectal cancer (CRC) including hereditary colorectal cancer and the importance of timely screening and prevention.  Their support also allows us to help sponsor prevention programs in New York City including screening efforts for the uninsured and innovative translational research projects focused on early age onset of colorectal cancer.

As a sponsor of the Summit you have the opportunity to reach thousands who join us each year to raise awareness of this deadly and yet preventable disease.

We are pleased to announce our partnership with CURE magazine to organize and host the nation’s first Colorectal Cancer (CRC) Heroes Award Event in conjunction with the Summit. The CRC Heroes event will recognize and honor those that are making a significant impact in the CRC space including patients, caregivers, nurses, and researchers.

If you are interested in joining our community of Sponsors, please look at our EAO-CRC Summit Corporate Sponsors Opportunities or the CURE Colorectal Cancer Heroes Award Event Sponsor Opportunities. Please contact us at 914.305.6675 with any questions.

CME INFORMATION

CME Accreditation:  This activity will be planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME).

Credit Designation:  TBD 

Certificate of Attendance:  TBD

Disclosure Policy:  The Colon Cancer Foundation adheres to the ACCME’s Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others, are required to disclose all relevant financial relationships with commercial interests. All relevant conflicts of interest will be resolved prior to the commencement of the activity.

REGISTRATION

Northwell Employee 2 Days (April 26 4:30 – 8:30 PM – Non CME – and April 27 7:30 AM – 5:30 PM)MD/PhD
NPs/Pas/RNs and Other Health Care Professionals
Patient/Survivor Advocate
Fellow/Resident/Med Student
200.00
170.00
55.00
55.00
Non – Northwell Employee 2 Days (April 26 4:30 – 8:30 PM – Non CME – and April 27 7:30 AM – 5:30 PM)MD/PhD
NPs/PAs/RNs Other Health Care Professionals
Patient/Survivor Advocate
Fellow/Resident/Med Student
230.00
200.00
55.00
55.00
Northwell Employee 1 day – April 26, 4:30 PM – 8:30 PM (not for CME) MD/PhDN
Ps/Pas/RNs and Other Health Care Professionals
Patient/Survivor Advocate
Fellow/Resident/Med Student
125.00
125.00
40.00
40.00
Non-Northwell Employee 1 day – April 26, 4:30 PM – 8:30 PM (not for CME) MD/PhD
NPs/PAs/RNs and Other Health Care Professionals
Patient/Survivor Advocate
Fellow/Resident/Med Student
150.00
150.00
40.00
40.00
Northwell Employee 1 day – April 27, 7:30 AM – 5:30 PM MD/PhD
NPs/Pas/RNs and Other Health Care Professionals
Patient/Survivor Advocate
Fellow/Resident/Med Studen
150.00
120.00
40.00
40.00
Non – Northwell Employee 1 day – April 27, 7:30 AM – 5:30 PM MD/PhD
NPs/PAs/RNs and Other Health Care Professionals
Patient/Survivor Advocate
Fellow/Resident/Med Student
180.00
150.00
40.00
40.00